IL27 and type 2 diabetes mellitus: Together, these findings suggest that IL-27 exerts both pro-inflammatory and anti-inflammatory effects in T2DM, depending on the stage of the disease and immune context, highlighting the need for further research to clarify its therapeutic potential.